Key result
Mechanical tricuspid valve replacement shows comparable 10-year survival and valve-related events versus bioprosthetic valves.
Why the study?
Does mechanical tricuspid valve replacement improve survival or reduce valve-related events compared to bioprosthetic valve replacement in patients with tricuspid valvular disease?
Population
104 consecutive patients with tricuspid valvular disease (71 women; mean age 57 ± 10.8 years)
Comparison
Mechanical tricuspid valve replacement (n=59) vs Bioprosthetic tricuspid valve replacement (n=45)
Design
Cohort
Follow-up
median 49.9 months (range 0-230 months)
Authors
Loading...
Should not yet change tricuspid valve selection; extends observational data but leaves open need for randomized confirmation.
Cohort (n=104)
Does mechanical tricuspid valve replacement improve survival or reduce valve-related events compared to bioprosthetic valve replacement in patients with tricuspid valvular disease?
Absolute Event Rate: 83.9% vs 61.4%
p-value: p=0.004 (unadjusted); 0.084 (adjusted)
Mechanical tricuspid valve replacement appears to have comparable long-term survival and valve-related event rates to bioprosthetic replacement after adjusting for baseline differences.
Cho et al. (2013) conducted a cohort in Tricuspid valvular disease (n=104). Mechanical tricuspid valve replacement vs. Bioprosthetic tricuspid valve replacement was evaluated on 10-year actuarial survival (p=0.004 (unadjusted); 0.084 (adjusted)). Mechanical tricuspid valve replacement was not inferior to bioprosthetic replacement for valve-related events and showed no significant difference in adjusted 10-year survival (P=0.084).
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: